Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001947684 | SCV002188733 | likely benign | Kabuki syndrome | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004538612 | SCV004726971 | uncertain significance | KMT2D-related disorder | 2024-02-27 | no assertion criteria provided | clinical testing | The KMT2D c.6997C>T variant is predicted to result in the amino acid substitution p.Pro2333Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0045% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |